MAY
4
Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen®
5
Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program
6
Myasthenia Gravis: How antibody testing helps you in the management of your patient
Give Us Your Feedback
Publication: Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)